Results 151 to 160 of about 20,405 (323)
L-3,4-dihydroxyphenylalanine (L-DOPA), a naturally occurring tyrosine derivative, is prevalent in environments that include mosquito habitats, potentially serving as part of their diet.
Emma Camacho +19 more
doaj +1 more source
The accumulation of l-3:4-dihydroxyphenylalanine in the tyrosinase-tyrosine reaction [PDF]
William C. Evans, Henry Stanley Raper
openalex +1 more source
THE METABOLISM OF 3,4-DIHYDROXYPHENYLALANINE
K N, SHAW, A, MCMILLAN, M D, ARMSTRONG
openaire +2 more sources
A New Phenotype–Genotype Correlation for FIG4 and Parkinson's Disease
Movement Disorders Clinical Practice, EarlyView.
Iro Boura +4 more
wiley +1 more source
Skin pigmentation is the consequence of melanin production and dispersion, this pigment is formed by a successive oxidation of L-Tyrosine into L-Dihydroxyphenylalanine (L-DOPA) and dopaquinone by Tyrosinase enzyme. Skin pigmentation irregularities become
Katalina MUÑOZ D. +4 more
doaj
Molecular and cellular determinants of L-Dopa-induced dyskinesia in Parkinson’s Disease
Treatment with L-3,4-dihydroxyphenylalanine (L-Dopa) compensates for decreased striatal dopamine (DA) levels and reduces Parkinson’s disease (PD) symptoms.
Federica Servillo +22 more
doaj +1 more source
High-Frequency Stimulation of the Subthalamic Nucleus and l-3,4-Dihydroxyphenylalanine InhibitIn VivoSerotonin Release in the Prefrontal Cortex and Hippocampus in a Rat Model of Parkinson's Disease [PDF]
Sylvia Navailles +4 more
openalex +1 more source
The “second‐hit” hypothesis proposes that both a genetic predisposition and an environmental insult—such as peripheral nerve trauma or spinal cord injury—are required for dystonia development. This review explores how neuroinflammation and maladaptive plasticity, triggered by nerve and spinal cord injury, contribute to dystonia pathogenesis.
Lisa Harder‐Rauschenberger +1 more
wiley +1 more source

